drugset / Trial / NCT03525405
A Study to Evaluate the Mass Balance of 14C-Napabucasin in Healthy Adult Male Subjects
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase I, single-center, open-label, single-sequence, study evaluating the absorption, metabolism, and excretion of napabucasin in healthy adult male volunteers using a mixture 14C-radiolabeled and unlabeled material.
Timeline
- Start
- 2018-05-18
- Primary completion
- 2018-06-02
- Completion
- 2018-06-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Napabucasin | Small molecule | 240 mg | — |
Indications
No indication recorded.